Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis

International Journal of Immunogenetics

Volumn 33, Issue 2, 2006, Pages 87-91

  Zaletel, K ^a   Krhin, B ^a   Gaberscek S ^a   Hojker, S ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HASHIMOTO DISEASE; HETEROZYGOTE; HUMAN; IMMUNOASSAY; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; EXONS; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THYROID GLAND;

EID: 33645114938     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2006.00574.x     Document Type: Article

References (37)

1. Akamizu T. Sale M.M. Rich S.S. Hiratani H. Noh J.Y. Kanamoto N. et al. 2000 Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10 851.
2. Anjos S. Nguyen A. Ounissi-Benkalha H. Tessier M.C. Polychronakos C. 2002 A common autoimmunity predisposing signal peptide variant of cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry 277 46478.
3. Anjos S.M. Tessier M.C. Polychronakos C. 2004 Association of the cytotoxic T lymphocyte associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. Journal of Clinical Endocrinology and Metabolism 89 6257.
4. Ban Y. Davies T.F. Greenberg D.A. Kissin A. Marder B. Murphy B. et al. 2003 Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes and Immunity 4 586.
5. Braun J. Donner H. Siegmund T. Walfish P.G. Usadel K.H. Badenhoop K. 1998 CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigen 51 563.
6. Deichmann K. Heinzmann E. Bruggenolte E. Forster J. Kuehr J. 1996 An MseI RFLP in the human CTLA-4 promotor. Biochemical and Biophysical Research Communications 225 817.
7. Donner H. Braun J. Seidl C. Rau H. Finke R. Ventz M. et al. 1997a Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. Journal of Clinical Endocrinology and Metabolism 82 4130.
8. Donner H. Rau H. Walfish P.G. Braun J. Siegmund T. Finke R. et al. 1997b CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 82 143.
9. Hall R. Owen S.G. Smart G.A. 1960 Evidence for a genetic predisposition to formation of thyroid autoantibodies. Lancet ii 187.
10. Hall R. Saxena K.M. Owen S.G. 1962 A study of the parents of patients with Hashimoto's disease. Lancet ii 1291.
11. Heward J.M. Allahabadia A. Armitage M. Hattersley A. Dodson P.M. Macleod K. et al. 1999 The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. Journal of Clinical Endocrinology and Metabolism 84 2398.
12. Heward J.M. Allahabadia A. Carr-Smith J. Daykin J. Cockram C.S. Gordon C. et al. 1998 No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clinical Endocrinology 49 331.
13. Johnson G.C.L. Esposito L. Barratt B.J. Smith A.N. Heward J. Genova G.D. et al. 2001 Haplotype tagging for the identification of common disease genes. Nature Genetics 29 233.
14. Kotsa K. Watson P.F. Weetman A.P. 1997 A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clinical Endocrinology 46 551.
15. Kouki T. Gardine C.A. Yanagawa T. DeGroot L.J. 2002 Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. Journal of Endocrinological Investigation 25 208.
16. Kouki T. Sawai Y. Gardine C.A. Fisfalen M.E. Alegre M.L. DeGroot L.J. 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology 165 6606.
17. Ligers A. Teleshova N. Masterman T. Huang W.X. Hillert J. 2001 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes and Immunity 2 145.
18. Maurer M. Loserth S. Kolb-Maurer A. Ponath A. Wiese S. Kruse N. et al. 2002 A polymorphism in the human cytotoxic T-lymphocyte antigen (CTLA4) gene (exon1 +49) alters T-cell activation. Immunogenetics 54 1.
19. Nithiyananthan R. Heward J.M. Allahabadia A. Franklyn J.A. Gough S.C. 2002 Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 1 3.
20. Park Y.J. Chung H.K. Park D.J. Kim W.B. Kim S.W. Koh J.J. et al. 2000 Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10 453.
21. Petrone A. Giorgi G. Galgani A. Alemanno I. Corsello S.M. Signore A. et al. 2005 CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15 232.
22. Petrone A. Giorgi G. Mesturino C.A. Capizzi M. Cascino I. Nistico L. et al. 2001 Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11 171.
23. Pfannenstiel P. Hotze L.A. Saller B. 1997 Schilddrüsenkrankheiten: Diagnose und Therapie p. 229. Berliner Medizinische Verlagsanstalt
24. Phillips D. McLachlan S. Stephenson A. Roberts D. Moffitt S. McDonald D. et al. 1990 Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. Journal of Clinical Endocrinology and Metabolism 70 742.
25. Phillips D.I. Prentice L. McLachlan S.M. Upadhyaya M. Lunt P.W. Rees Smith B. 1991 Autosomal dominant inheritance of the tendency to develop thyroid autoantibodies. Experimental and Clinical Endocrinology and Diabetes 97 170.
26. Terauchi M. Yanagawa T. Ishikawa N. Ito K. Fukazawa T. Maruyama H. et al. 2003 Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population. Journal of Endocrinological Investigation 26 1208.
27. Tomer Y. Davies T.F. 2003 Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocrine Reviews 24 694.
28. Tomer Y. Greenberg D.A. Barbesino G. Con cepcion E. Davies T.F. 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid antibody production. Journal of Clinical Endocrinology and Metabolism 86 1687.
29. Ueda H. Howson J.M. Esposito L. Heward J. Snook H. Chamberlain G. et al. 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 506.
30. Vaidya B. Imrie H. Perros P. Young E.T. Kelly W.F. Carr D. et al. 1999 The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Human Molecular Genetics 8 1195.
31. Vaidya B. Oakes E.J. Imrie H. Dickinson A.J. Perros P. Kendall-Taylor P. et al. 2003 CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clinical Endocrinology 58 732.
32. Wang X.B. Zhao X. Giscombe R. Lefvert A.K. 2002 A CTLA-4 gene polymorphism at position-318 in the promoter region affects the expression of protein. Genes and Immunity 3 233.
33. Weng Y.C. Wu M.J. Lin W.S. 2005 CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population. Annals of Clinical and Laboratory Science Online 35 259.
34. Xu Y. Graves P.N. Tomer Y. Davies T.F. 2002 CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cellular Immunology 215 133.
35. Yanagawa T. Hidaka Y. Guimaraes V. Soliman M. DeGroot L.J. 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. Journal of Clinical Endocrinology and Metabolism 80 41.
36. Zaletel K. Krhin B. Gaberšček S. Pirnat E. Hojker S. 2002 The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 12 373.
37. Zhao J.H. 2002 ) 2 ld - Two-Locus Linkage Disequilibrium (LD) Calculator. http://www.iop.kcl.ac.uk/loP/Departments/PsychMed/GepiBSt/software.shtml (accessed 18 July 2005).